Wacker applies for EU funding for production of green hydrogen and renewable methanol at site in Burghausen, Germany; project is key to company's target for company's GHG reduction targets, including net-zero production by 2045

Sample article from our Bioeconomy

MUNICH, Germany , March 7, 2022 (press release) –

  • PROJECT IS A KEY BUILDING BLOCK IN MEETING THE GOAL OF NET-ZERO PRODUCTION BY 2045
  • SOME €100 MILLION TO BE INVESTED, WITH THE AMOUNT OF FUNDING APPLIED FOR IN THE DOUBLE-DIGIT MILLIONS
  • CEO CHRISTIAN HARTEL: “BY PRODUCING GREEN HYDROGEN AND USING IT AS A RAW MATERIAL, WE ARE MAKING AN ESSENTIAL CONTRIBUTION TOWARD MARKEDLY REDUCING FOSSIL RESOURCES IN CHEMICAL PROCESSES AND PRODUCTS”

Wacker Chemie AG has re-applied for European Union funding for its project for producing green hydrogen and renewable methanol at its Burghausen site. The WACKER Group had applied for funding from the European Commission’s EU Innovation Fund for its RHYME (Renewable Hydrogen and Methanol) Bavaria project in 2020. RHMYE Bavaria prevailed over more than two hundred other projects during the initial evaluation phase. Yet despite being given an excellent rating by the jury, it was unable to qualify during the final stage.

Wacker Chemie AG has re-applied for European Union funding for its project for producing green hydrogen and renewable methanol at its Burghausen site. The WACKER Group had applied for funding from the European Commission’s EU Innovation Fund for its RHYME (Renewable Hydrogen and Methanol) Bavaria project in 2020. RHMYE Bavaria prevailed over more than two hundred other projects during the initial evaluation phase. Yet despite being given an excellent rating by the jury, it was unable to qualify during the final stage.

“The EU has now adjusted its selection criteria as well as increasing annual funding from €1 billion to €1.5 billion, which makes it possible to fund a medium-sized, albeit highly innovative project such as RHYME Bavaria,” explained Christian Hartel, president and CEO of Wacker Chemie AG. “That’s why we think resubmission of this trailblazing project stands a good chance of receiving the necessary EU funding. RHYME Bavaria is a key building block in meeting our ambitious climate-protection and sustainability targets. We want to halve our absolute greenhouse gas emissions by 2030 and achieve net-zero production by 2045.”

RHYME Bavaria refers to a 20-megawatt electrolysis plant that will produce hydrogen from water using renewable electricity. WACKER intends to use carbon dioxide (CO2) from existing production processes to turn this green hydrogen into renewable methanol, a key starting material for making chemical products such as silicones.

The expected capacity of this plant is 15,000 metric tons of methanol per year. Compared with existing manufacturing processes, the new approach to methanol production could avoid CO2 emissions completely. The quantities of carbon dioxide required by RHYME Bavaria would no longer be emitted into the atmosphere. Instead, they would be recycled as a raw material in a chemical production process.

WACKER estimates it will invest some €100 million in the project, with the amount of EU funding applied for in the double-digit millions of euros. The EU’s Innovation Fund has a budget of €10 billion to support innovative low-carbon technologies and processes in energy-intensive industries until 2030.


Burghausen is WACKER’s largest production site worldwide. About 8,000 employees work there. (Photo: Wacker Chemie AG)
“Our RHYME Bavaria goal is to narrow our carbon footprint even further,” explained CEO Christian Hartel. “By producing green hydrogen and using it as a material, we are making an essential contribution toward markedly reducing fossil resources in chemical processes and products.”

Such a project was nevertheless still not economical under current conditions, Hartel continued. “That’s why we need state funding to make the move to a renewable hydrogen economy possible.” He added that investment grants weren’t enough. Operating costs needed to be subsidized too, so that a plant such as RHYME Bavaria could be operated profitably in the first few years. What was needed in the medium term, he said, was an electricity price of about 4 cents per kilowatt-hour so that this kind of energy-intensive project did not require funding in order to be profitable.

“As an energy-intensive company, we have been in favor of an industrial electricity price for many years now in order to maintain our international competitiveness even as we accelerate our move toward net-zero status,” he emphasized. “Our processes are among the most efficient in the world – making them some of the most economical too,” he added. “Yet, in Germany, we have to pay an electricity price that is much higher than what our competitors in other parts of the world pay. That hits our entire industry hard.”

Hartel went on to say that precisely the exorbitant rises in German electricity prices over recent months therefore showed how important an internationally competitive industrial electricity price was for export-driven sectors such as the chemical industry. The WACKER CEO also demanded a considerable and rapid expansion of renewable energy sources. Only in this way, he explained, could sufficient amounts of competitively priced green hydrogen be made available for projects such as RHYME Bavaria.

“A project such as RHYME Bavaria might be the initial step in defossilizing chemical processes and products in Bavaria’s so-called chemical triangle,” he added. The chemical triangle is a region in the southeast of Bavaria which is home to numerous chemical companies, including WACKER’s Burghausen site. Today’s integrated hydrogen network in the region could evolve over time into a Bavarian center for green hydrogen. Against this background, Hartel felt that it would be an important political signal if RHYME Bavaria – unlike the outcome of the initial evaluation phase – became the first German project to be subsidized by the EU Innovation Fund.

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.

See our dashboard in action - schedule an demo
Jason Irving
Jason Irving
- SVP Enterprise Solutions -

We offer built-to-order bioeconomy coverage for our clients. Contact us for a free consultation.

About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025

+1 (310) 553 0008

About Cookies On This Site

We collect data, including through use of cookies and similar technology ("cookies") that enchance the online experience. By clicking "I agree", you agree to our cookies, agree to bound by our Terms of Use, and acknowledge our Privacy Policy. For more information on our data practices and how to exercise your privacy rights, please see our Privacy Policy.